T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis

被引:59
作者
Honda, K
Nakamura, K
Matsui, N
Takahashi, M
Kitamura, Y
Mizutani, T
Harada, N
Nawata, H
Hamano, S
Yoshida, H
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Fac Med Sci, Dept Parasitol, Fukuoka 8128582, Japan
[3] Saga Univ, Fac Med, Dept Biomol Sci, Saga 840, Japan
关键词
inflammatory bowel diseases; interleukin-27; receptor; dextran sulfate sodium; colitis;
D O I
10.1097/01.MIB.0000191611.05466.1f
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: WSX-1, a component of the interleukin (IL)-27 receptor, is a novel class I cytokine receptor with homology to the IL-12 receptor 132 chain. Initially, WSX-1 signaling was reported to play an important role in the promotion of T helper-1 responses, but recent reports have revealed an anti-inflammatory property in WSX-1 signaling. In the Present Study, we investigated the role of IL-27/WSX-1 signaling in a murine colitis model, dexn-an sulfate sodium (DSS) colitis, by using WSX-1 knockout (KO) mice. Methods: First, we observed whether WSX-1 KO mice developed colitis spontaneously. Second, we induced DSS colitis in WSX-1 KO and wild-type (WT) mice. Results: WSX-1 KO mice were observed not to develop colitis spontaneously. The severity of DSS colitis was decreased in WSX-1 KO mice in comparison with WT mice in association with a reduced production of interferon-gamma, IL-6, and tumor necrosis factor-alpha by lamina propria mononuclear cells from WSX-1 KO mice and the absence of T-bet expression in the colon from WSX-1 KO mice. Conclusions: This study revealed the inflammatory property of IL-27/WSX-1 signaling in intestinal inflammation. As a result. IL27/WSX-1 signal pathway may thus be a promising candidate for the therapeutic intervention of human inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
引用
收藏
页码:1044 / 1052
页数:9
相关论文
共 35 条
[1]
Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis:: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine [J].
Andres, PG ;
Beck, PL ;
Mizoguchi, E ;
Mizoguchi, A ;
Bhan, AK ;
Dawson, T ;
Kuziel, WA ;
Maeda, N ;
MacDermott, RP ;
Podolsky, DK ;
Reinecker, HC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6303-6312
[2]
Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice [J].
Axelsson, LG ;
Landstrom, E ;
Goldschmidt, TJ ;
Gronberg, A ;
BylundFellenius, AC .
INFLAMMATION RESEARCH, 1996, 45 (04) :181-191
[3]
WSX-1: A key role in induction of chronic intestinal nematode infection [J].
Bancroft, AJ ;
Humphreys, NE ;
Worthington, JJ ;
Yoshida, H ;
Grencis, RK .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7635-7641
[4]
Development of Th1-type immune responses requires the type I cytokine receptor TCCR [J].
Chen, Q ;
Ghilardi, N ;
Wang, H ;
Baker, T ;
Xie, MH ;
Gurney, A ;
Grewal, IS ;
de Sauvage, FJ .
NATURE, 2000, 407 (6806) :916-920
[5]
An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease [J].
Christ, AD ;
Stevens, AC ;
Koeppen, H ;
Walsh, S ;
Omata, F ;
Devergne, O ;
Birkenbach, M ;
Blumberg, RS .
GASTROENTEROLOGY, 1998, 115 (02) :307-313
[6]
DEXTRAN SULFATE SODIUM-INDUCED COLITIS OCCURS IN SEVERE COMBINED IMMUNODEFICIENT MICE [J].
DIELEMAN, LA ;
RIDWAN, BU ;
TENNYSON, GS ;
BEAGLEY, KW ;
BUCY, RP ;
ELSON, CO .
GASTROENTEROLOGY, 1994, 107 (06) :1643-1652
[7]
Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
[8]
Characterisation of acute murine dextran sodium sulphate colitis:: Cytokine profile and dose dependency [J].
Egger, B ;
Bajaj-Elliott, M ;
MacDonald, TT ;
Inglin, R ;
Eysselein, VE ;
Büchler, MW .
DIGESTION, 2000, 62 (04) :240-248
[9]
SPONTANEOUS RELEASE OF INTERFERON-GAMMA BY INTESTINAL LAMINA PROPRIA LYMPHOCYTES IN CROHNS-DISEASE - KINETICS OF INVITRO RESPONSE TO INTERFERON-GAMMA INDUCERS [J].
FAIS, S ;
CAPOBIANCHI, MR ;
PALLONE, F ;
DIMARCO, P ;
BOIRIVANT, M ;
DIANZANI, F ;
TORSOLI, A .
GUT, 1991, 32 (04) :403-407
[10]
Fuss IJ, 1996, J IMMUNOL, V157, P1261